POM-V Prescription Required

ReproCyc ParvoFLEX Suspension for Injection for Pigs

Active ingredient: Porcine parvovirus 27a viral protein 2

Form

Injection

Species

Pigs

Manufacturer

Boehringer Ingelheim Vetmedica GmbH

VMD MA No.

EU/2/19/237/001-006

What it's used for

Onset of immunity: from the beginning of the gestational period. Duration of immunity: 6 months

Full indications, dosage and side effects ↓

View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Porcine parvovirus 27a viral...

1

Ask your vet for a written prescription

They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
2

Fill it at a registered online retailer

The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Your prescription rights → VMD register of retailers →

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

ReproCyc ParvoFLEX Suspension for Injection for Pigs — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

Onset of immunity: from the beginning of the gestational period.
Duration of immunity: 6 months

Avoid introduction of contamination during use.
Primary vaccination scheme:
For pigs previously non-vaccinated against porcine parvovirus:
Two intramuscular injections of one dose, 3 weeks apart.
The second dose being given at least 3 weeks before mating.
Re-vaccination scheme:
One intramuscular injection of one dose at least every 6 months is recommended in a
whole herd programme (see section 3.2).
Mixing with ReproCyc PRRS EU:
The full content of one vial of ReproCyc ParvoFLEX should be used to reconstitute the
lyophilisate of one vial of ReproCyc PRRS EU. ReproCyc ParvoFLEX hereby replaces
the solvent of ReproCyc PRRS EU.
Ensure that the lyophilisate is completely reconstituted before use.
Administer a single dose (2 ml) of the mixture intramuscularly.
The following corresponding presentations (doses) can be mixed:
ReproCyc ParvoFLEXReproCyc PRRS EU (lyophilisate)10 doses (20 ml)10 doses 50 doses (100 ml)50 doses100 doses (200 ml)100 doses
The package leaflet of ReproCyc PRRS EU should also be consulted before the
administration of the mixed veterinary medicinal product.

None.

Pigs:
Very common
(>1 animal / 10 animals treated):
Injection site swelling
; Injection site reddening
Common
(1 to 10 animals / 100 animals
treated):
Elevated temperature
.
Transient, up to 4 cm, resolve within two to five days without treatment.
Body temperature resolve spontaneously within 24 to 48 hours.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder or its local representative or the national
competent authority via the national reporting system. See the package leaflet for
respective contact details.

Vaccinate healthy animals only.

Special precautions for safe use in the target species:
Not applicable.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
Not applicable.
Special precautions for the protection of the environment:
Not applicable.

Safety and efficacy data are available which demonstrate that this vaccine can be mixed
with ReproCyc PRRS EU and administered at one injection site.
No information is available on the safety and efficacy of this vaccine when used with any
other veterinary medicinal product except the product mentioned above. A decision to
use this vaccine before or after any other veterinary medicinal product therefore needs to
be made on a case-by-case basis.

Store and transport refrigerated (2 °C – 8 °C).
Do not freeze.
Keep the bottle in the outer carton in order to protect from light.

Zero days.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.